Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of $80.00. The company’s shares ...

RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the shares. The company is past its earnings trough with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With children off school and winter bugs still going around, pharmacies are being highlighted as a quick and convenient source for health advice and ... the Pharmacy First scheme allows patients ...

Our advice columnists have heard it all over the years—so we’re diving into the Dear Prudence archives to share classic letters with our readers. Submit your own questions to Prudie here.

How to Do It is Slate’s sex advice column. Have a question? Send it to Stoya and Rich here. It’s anonymous! Dear How to Do It, I have a good friend and much of our mutual bond is over our ...

Before locking in your NASCAR Fantasy lineups for the 2025 Daytona 500 at Daytona International Speedway, be sure to check out the optimal NASCAR at Daytona Fantasy strategy and advice from ...

The healthcare industry experienced a rollercoaster of a year in 2024, with pharmacy benefits undergoing significant shifts. Rising drug costs, advancements in medication technology, and changing ...

Horacio Falcão and Thomas Wiegelmann Paul Ingram Kevin Evers A roundup of Harvard Business Review’s most popular ideas and advice. Resources, practical advice, and personal stories to lift you ...

Timothy Snyder, Yale historian and author of "On Tyranny" and "On Freedom," talks with Rachel Maddow about how citizens resist the autocratic tendencies of leaders like Donald Trump.Jan. 21, 2025 ...